← All organizations
Highest phase reached
Phase 4
First clinical trial
Dec 1, 2016Last known activity
Mar 14, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (13 distinct, 7 trials)
Phase 4 (5 own, 0 via acquisition)
Phase 3 (2 own, 0 via acquisition)
Other trials (6 own, 0 via acquisition)
Indications
Recent trials (10)
- NCT06319144Sponsor investigatorN/AMar 14, 2024
- NCT06319144Lead sponsorN/AMar 14, 2024
- NCT05932160Overall official - principal investigatorN/AJun 1, 2023
- NCT05932160Reponsible party - principal investigatorN/AJun 1, 2023
- NCT05932160Lead sponsorN/AJun 1, 2023
- NCT05870683CollaboratorN/AMay 24, 2023
- NCT05901779CollaboratorN/AApr 1, 2023
- NCT05586113CollaboratorPhase 4Nov 20, 2022
- NCT02838992CollaboratorPhase 4Feb 1, 2017
- NCT02985372CollaboratorPhase 3Dec 1, 2016
Details
- Last known activity
- Mar 14, 2024